Connacht Asset Management LP Astrazeneca PLC Transaction History

Connacht Asset Management LP

  • $16.3 Million
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$63.15 - $71.6 $578,769 - $656,214
-9,165 Reduced 62.59%
5,478 $380,000
Q4 2022

Feb 14, 2023
SELL
$54.21 - $70.44 $134,657 - $174,972
-2,484 Reduced 14.5%
14,643 $992,000
Q3 2022

Nov 14, 2022
SELL
$53.02 - $135.75 $306,879 - $785,721
-5,788 Reduced 25.26%
17,127 $939,000
Q2 2022

Aug 15, 2022
BUY
$59.26 - $71.14 $1.36 Million - $1.63 Million
22,915 New
22,915 $1.51 Million

Others Institutions Holding AZN

# of Institutions
1,343
Shares Held
492M
Call Options Held
4.99M
Put Options Held
3.19M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $233B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Connacht Asset Management LP Portfolio

Follow Connacht Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connacht Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Connacht Asset Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email